Clinical Trial Update: Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the effect of a low protein diet on top of dapagliflozin in patients with chronic kidney disease and type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Anemia Working Group Romania | Conditions: Chronic Kidney Diseases, Type 2 Diabetes Mellitus | Phase 4 | Status: UNKNOWN